DEBM_CompanyBanner_International_LG

Debiopharm International S.A.


developing &
financing
innovative
drugs

Business

Discover our Pipeline

10 programs from discovery to phase III

Discover
Latest news
October 11, 2018

Debiopharm International SA and the Paul Scherrer Institute announce a licensing agreement for the development of a novel targeted radiotherapeutic…

Read more
May 8, 2018

FDA Grants Fast Track designation to Debiopharm International’s Debio 1347 for the treatment of patients with unresectable or metastatic tumors…

Read more
See all news
Agenda
Let's meet

ESCMID 2018

September 4 - 7, 2018 Lisbon, Portugal Discover
See all events

Business model

Your candidates turned into solutions for patients

In-licensing Deal Focus

You want to partner with us? Discover what kind of projects we look for

Partners
Universities, Biotech, Big pharma
Main areas
Oncology, Infectious Diseases
Development stages
From candidate to clinical phase II
Molecules
Small molecules, antibodies and peptides
Chief Executive Officer, Debiopharm International S.A.
Management

Discover the members who guide and bring long-term vision to the company

Discover
Press releases

Latest Debiopharm International's announcements for media and journalists

Discover
Publications

Discover Debiopharm International's latest publications and posters

Discover
Contact us

Would like to partner with us? Got a question or a comment? Get in touch!

Discover